List of Excipients in API maxzide
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing maxzide
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Mylan Pharmaceuticals Inc | MAXZIDE-25 | maxzide | 0378-0464 | CELLULOSE, MICROCRYSTALLINE | |
| Mylan Pharmaceuticals Inc | MAXZIDE-25 | maxzide | 0378-0464 | CROSCARMELLOSE SODIUM | |
| Mylan Pharmaceuticals Inc | MAXZIDE-25 | maxzide | 0378-0464 | D&C YELLOW NO. 10 | |
| Mylan Pharmaceuticals Inc | MAXZIDE-25 | maxzide | 0378-0464 | FD&C BLUE NO. 1 | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Detailed excipient profiles for maxzide
Excipient focus: CELLULOSE, MICROCRYSTALLINE
maxzide drug variants containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | maxzide | 0378-0464 |
| >Company | >Ingredient | >NDC |
maxzide drug variants not containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| No data available in table | ||
| >Company | >Ingredient | >NDC |
Excipient focus: CROSCARMELLOSE SODIUM
maxzide drug variants containing CROSCARMELLOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | maxzide | 0378-0464 |
| >Company | >Ingredient | >NDC |
maxzide drug variants not containing CROSCARMELLOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| No data available in table | ||
| >Company | >Ingredient | >NDC |
Excipient focus: D&C YELLOW NO. 10
maxzide drug variants containing D&C YELLOW NO. 10
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | maxzide | 0378-0464 |
| >Company | >Ingredient | >NDC |
maxzide drug variants not containing D&C YELLOW NO. 10
| Company | Ingredient | NDC |
|---|---|---|
| No data available in table | ||
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C BLUE NO. 1
maxzide drug variants containing FD&C BLUE NO. 1
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | maxzide | 0378-0464 |
| >Company | >Ingredient | >NDC |
maxzide drug variants not containing FD&C BLUE NO. 1
| Company | Ingredient | NDC |
|---|---|---|
| No data available in table | ||
| >Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
maxzide drug variants containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | maxzide | 0378-0464 |
| >Company | >Ingredient | >NDC |
maxzide drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| No data available in table | ||
| >Company | >Ingredient | >NDC |
Excipient focus: POWDERED CELLULOSE
maxzide drug variants containing POWDERED CELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | maxzide | 0378-0464 |
| >Company | >Ingredient | >NDC |
maxzide drug variants not containing POWDERED CELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| No data available in table | ||
| >Company | >Ingredient | >NDC |
Excipient focus: SILICON DIOXIDE
maxzide drug variants containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | maxzide | 0378-0464 |
| >Company | >Ingredient | >NDC |
maxzide drug variants not containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| No data available in table | ||
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM LAURYL SULFATE
maxzide drug variants containing SODIUM LAURYL SULFATE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | maxzide | 0378-0464 |
| >Company | >Ingredient | >NDC |
maxzide drug variants not containing SODIUM LAURYL SULFATE
| Company | Ingredient | NDC |
|---|---|---|
| No data available in table | ||
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2025 - 2026
NCE-1 Patent Challenge Dates 2025 - 2026
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2025, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Follow DrugPatentWatch:
